Dawnzera is the third medicine cleared by U.S. regulators this year for the rare genetic condition, and the second wholly owned medicine Ionis has brought to market.

Senior author Elias Sayour, M.D., Ph.D., a UF Health pediatric oncologist, said the results reveal a potential new treatment path — an alternative to surgery, radiation, and chemotherapy — with broad ...

The Institute of Cancer Research, London, has published two major studies demonstrating how pairing a cancer-killing reovirus with targeted thera ...

A previously unknown virus in farmed Pacific oysters may hold the key to mass die-offs in the multimillion-dollar industry, according to research from the University of British Columbia (UBC) in ...

The quest for a vaccine against HIV has been going on for about 40 years — almost as long as the virus that causes AIDS has ...

Researchers warn that halting federal contracts for mRNA vaccine research could weaken pandemic preparedness and slow medical advances.

Samuel Penwell Winfried Wiegraebe Bruker News Medical talks to Samuel Penwell and Winfried Wiegraebe at Bruker about how the Vutara VXL enables robust, high-throughput 3D super-resolution via ...

COCP READ THE FULL COCP RESEARCH REPORT Business Update Norovirus Challenge Study to Commence in 4Q25 Cocrystal Pharma, Inc. ...

In 1957, just four years after Francis Crick and other scientists solved the riddle of DNA’s structure—the now famous double ...

Amy Lynn talks with Dr. Reddy about the Greeneville office of RNA Medical Aesthetics. Dr. Reddy shares with us how she felt ...

STONY BROOK, NY / ACCESS Newswire / August 14, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company ...

Cancer research has long looked at bacteria and viruses as separate tools for therapy. Now, researchers are showing that the ...